|
Periprocedural data
|
|
Technical success rate (%)
|
243 (60%)
|
|
Procedural success rate (%)
|
400 (99%)
|
|
Vessel perforation (%)
|
5 (1%)*
|
|
Vessel perforation requiring covered stent placement (%)
|
2 (0.5%)*
|
|
Symptomatic distal embolisation (%)
|
0
|
|
Asymptomatic distal embolisation (%)
|
10 (2%)**
|
|
Persistent vessel occlusion (%)
|
0
|
|
Stent placement in all patients (%)
|
70 (17%)
|
|
Stent placement with iliac lesions (%)
|
19 (86%)
|
|
Stent placement with CFA lesions (%)
|
2 (4%)
|
|
Stent placement with femoropopliteal lesions (%)
|
48 (16%)
|
|
Stent placement with BTK lesions (%)
|
6 (3%)
|
|
Treatment with DCB in CFA segments (%)
|
52 (100%)
|
|
Treatment with DCB in femoropopliteal segments (%)
|
299 (97%)
|
|
Treatment with DCB in BTK segments (%)
|
37 (21%)
|
|
Treatment with scoring balloon in CFA segments (%)
|
26 (50%)
|
|
Treatment with scoring balloon in femoropopliteal segments (%)
|
68 (22%)
|
|
Treatment with scoring balloon in BTK segments (%)
|
12 (7%)
|
|
Mean number of DCB in patients with femoropopliteal lesions (%)
|
2.4±1.1
|
|
Mean number of stents in patients with femoropopliteal lesions (%)
|
1.4±0.7
|
|
Post-procedural data
|
|
Follow-up data available
|
365 (91%)
|
|
TLR during follow-up (%)
|
15.9%
|
|
*In 3 cases requiring prolonged balloon inflation only and in 2 cases requiring the implantation of a covered stent. **All managed using catheter aspiration and without resulting in vessel occlusion or clinical symptoms. No filter protection devices were used in any patients. Mean of 15.7±10.2 months of follow-up. BTK: below-the-knee; CFA: common femoral artery; DCB: drug-coated balloon; TLR: target lesion revascularisation
|
